AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal Garima29 March 2019 9:15 AM ISTUnder the deal, AstraZeneca will pay Daiichi up to $6.9 billion, including a $1.35 billion upfront payment. The two companies will share development...
Pfizer Japan recalls high BP drug over cancer-causing impurity Farhat Nasim11 Feb 2019 3:47 PM ISTTOKYO - The Japanese subsidiary of Pfizer Inc is recalling a drug for high BP ( blood pressure) which was found to contain a carcinogenic substance in...